₹704.00
+13.60 (+1.97%)
As of 23 Sept 2026, Bliss GVS Pharma Ltd share price is ₹704.00. The stock opened at ₹704.00 and had closed at ₹690.40 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹118.35 and a high of ₹733.75. In terms of performance, Bliss GVS Pharma Ltd share price has increased by 234.42% over the past six months and has increased by 356.01% over the last year.
BLISSGVS Stock Price Chart
Bliss GVS Pharma Ltd Overview
Market cap₹7,341 Crs
Volume6,698
Prev. Close₹690.40
Year range₹118.35 - ₹733.75
ISININE416D01022
About BLISSGVS
Bliss GVS Pharma is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
Bliss GVS Pharma Ltd Historical Performance
1 Month Return18.57%
6 Month Return254.23%
3 Year Return651.74%
3 Month Return45.87%
1 Year Return356.01%
5 Year Return520.86%
Bliss GVS Pharma Ltd Fundamentals
ROCE(TTM)12.29%
P/E Ratio (TTM)64.16
P/B Ratio6.35
Debt to Equity0.01
ROE8.39%
EPS (TTM)10.90
Dividend Yield0.14%
Book Value108.65
Profit Margin14.71%
Operating Margin15.33%
Bliss GVS Pharma Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 773.53 | 703.42 | 638.96 | 649.11 | 668.99 |
| EBITDA | 175.59 | 127.80 | 99.59 | 140.92 | 144.57 |
| Net Profit | 96.87 | 68.97 | 50.64 | 85.48 | 92.66 |
| EPS | 9.17 | 6.56 | 4.85 | 8.23 | 8.97 |
Bliss GVS Pharma Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 668.50 |
| Resistance 1 (R1) | 701.35 |
| Pivot Point | 679.45 |
Bliss GVS Pharma Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 08-Jul-2026 | 12-May-2026 | 08-Jul-2026 | Final | ₹1.00 |
| 18-Feb-2026 | 10-Feb-2026 | 18-Feb-2026 | Interim | ₹0.50 |
| 24-Jul-2025 | 12-May-2025 | 24-Jul-2025 | Final | ₹0.50 |
| 18-Jul-2024 | 02-May-2024 | 19-Jul-2024 | Final | ₹0.50 |
| 12-Jul-2023 | 11-May-2023 | 13-Jul-2023 | Final | ₹0.50 |
BLISSGVS Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Nandkumar Kashinath Chodankar | Chairman |
| Shilpa Bhatia | Non Executive Independent Director |
| Shibroor N Kamath | Managing Director & Chief Executive Officer |
Bliss GVS Pharma Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,850.00+0.19% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,434.00+0.88% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,933.50-0.03% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Bliss GVS Pharma Ltd today is ₹704.00 on NSE and ₹704.00 on BSE.
- The 52-week high of Bliss GVS Pharma Ltd is ₹733.75, while the 52-week low is ₹118.35.
- The current market capitalisation of Bliss GVS Pharma Ltd is approximately ₹7,341 crore.
- The P/E (Price-to-Earnings) ratio of Bliss GVS Pharma Ltd is 19.97. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Bliss GVS Pharma Ltd is 2.02. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Bliss GVS Pharma Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for BLISSGVS on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Bliss GVS Pharma Ltd has delivered a return of approximately 651.74%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Bliss GVS Pharma Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 35.01% promoters, 7.82% FIIs, 9.47% DIIs, and 29.77% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
